INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 222 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.18 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $724,000 | -80.5% | 10,905 | -67.1% | 0.00% | -84.6% |
| Q1 2019 | $3,711,000 | +988.3% | 33,175 | +1128.7% | 0.01% | +1200.0% |
| Q3 2018 | $341,000 | +8.6% | 2,700 | -27.8% | 0.00% | 0.0% |
| Q2 2018 | $314,000 | -44.9% | 3,740 | -61.9% | 0.00% | -66.7% |
| Q3 2017 | $570,000 | +54.5% | 9,820 | +222.0% | 0.00% | +50.0% |
| Q2 2017 | $369,000 | -29.4% | 3,050 | -34.1% | 0.00% | -33.3% |
| Q1 2017 | $523,000 | +24.5% | 4,627 | +17.1% | 0.00% | 0.0% |
| Q4 2016 | $420,000 | -46.1% | 3,952 | -16.5% | 0.00% | -40.0% |
| Q3 2016 | $779,000 | +99.2% | 4,735 | +72.7% | 0.01% | +66.7% |
| Q2 2016 | $391,000 | +11.4% | 2,741 | +0.2% | 0.00% | 0.0% |
| Q1 2016 | $351,000 | +273.4% | 2,735 | +336.2% | 0.00% | +200.0% |
| Q4 2015 | $94,000 | -85.8% | 627 | -84.3% | 0.00% | -83.3% |
| Q3 2015 | $663,000 | +1200.0% | 4,000 | +2122.2% | 0.01% | – |
| Q1 2015 | $51,000 | +325.0% | 180 | +125.0% | 0.00% | – |
| Q4 2014 | $12,000 | 0.0% | 80 | +60.0% | 0.00% | – |
| Q3 2014 | $12,000 | – | 50 | -75.0% | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 200 | -77.8% | 0.00% | – |
| Q1 2014 | $7,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |